glp 1 microdosing canada GLP-1 Microdosing GLP-1: Understanding the Risks

This article will be updated as new research emerges

The FDA and FTC have both warned about deceptive claims from weight loss patch companies, highlighting how risky these products can be

In this article, we will dive deeper into what happens to muscle mass on GLP-1s, why creatine matters, and a practical plan you can follow to protect muscle tissue while you lose weight

doi:10.1136/bmjopen-2012-001986., Edwards CM, Todd JF, Ghatei MA, Bloom SR: Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation

Zhou L, Qu H, Yang L, et al